Management of women who test positive for high-risk types of human papillomavirus: the HART studyJack Cuzick, Peter Sasieni, Claire Brooks et al.|The Lancet|2003Cited by 505
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441
Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.Ian Jacobs, D Oram|BMJ|1993Cited by 366
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>Xin Yang, Mark E. Robson, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2020Cited by 163
Expression of vascular endothelial growth factor (VEGF)‐C and VEGF‐D, and their receptor VEGFR‐3, during different stages of cervical carcinogenesisPhilippe Van Trappen, Ian Jacobs, Dawn Steele et al.|The Journal of Pathology|2003Cited by 147